| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 21, 2024 |
| Group Lead, AI Products Engineering |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Окт. 22, 2024 |
| Customer Insights & Product Manager - Neurology & Immunology |
Warsaw |
Poland |
International |
Innovative Medicines |
Marketing |
Окт. 22, 2024 |
| Strategy Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Marketing |
Окт. 22, 2024 |
| Associate Director, Digital Analytics - HQ based - East Hanover, NJ |
East Hanover |
USA |
US |
Innovative Medicines |
Marketing |
Окт. 09, 2024 |
| Director, Marketing & Digital Data Solution |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Окт. 10, 2024 |
| Director Data Stratagy |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Окт. 10, 2024 |
| Senior Analyst, Product Management |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Окт. 10, 2024 |
| ASCVD Brand Manager |
Seoul |
South Korea |
International |
Innovative Medicines |
Marketing |
Септ. 03, 2024 |
| Senior Manager, Marketing- Cardiovascular |
Makati City |
Philippines |
International |
Innovative Medicines |
Marketing |
Септ. 05, 2024 |
| Manager Data Science |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Септ. 06, 2024 |
| Manager Data Science |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Септ. 09, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Customer Experience and Omnichannel Manager |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 18, 2024 |
| Spécialiste en marketing |
Montreal |
Canada |
International |
Innovative Medicines |
Marketing |
Окт. 16, 2024 |
| Gestionnaire des opérations des PSP |
Montreal |
Canada |
International |
Innovative Medicines |
Marketing |
Окт. 21, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Chef de Produit Snr en Dermatologie H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Marketing |
Окт. 25, 2024 |
| Chef de produit rhumatologie H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Marketing |
Окт. 25, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Innovation & Business Excellence Project Manager |
Milano |
Italy |
International |
Innovative Medicines |
Marketing |
Окт. 08, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Solution Design |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Септ. 03, 2024 |
| TA Strategy Lead - GenMed |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 02, 2024 |
| CX strategy |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 04, 2024 |
| TA Strategy Lead, RLT (Prostate Cancer) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 07, 2024 |
| Lead, Integrated Insights & Planning_市場調査 |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 07, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Associate Marketing |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Юли 08, 2024 |
| 区域市场组经理 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Marketing |
Юли 28, 2024 |
| (高级)区域市场经理 |
Xian (Shanxi Province) |
China |
International |
Innovative Medicines |
Marketing |
Септ. 05, 2024 |
| (高级)地区经理 |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Marketing |
Септ. 12, 2024 |
| Senior Area Marketing Manager |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Marketing |
Окт. 15, 2024 |
| Financial Accounting Specialist (m/w/d) |
Schaftenau |
Austria |
Finance |
CTS |
Audit & Finance |
Септ. 13, 2024 |
| Tax Manager m/w/d) |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
Finance |
Corporate |
Audit & Finance |
Окт. 16, 2024 |
| Senior FRA Specialist GL |
Prague |
Czech Republic |
Finance |
CTS |
Audit & Finance |
Септ. 26, 2024 |
| Comptable Général(e) Expérimenté(e) H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Finance |
CTS |
Audit & Finance |
Септ. 27, 2024 |
| R2R Lead Israel |
Israel |
Israel |
Finance |
CTS |
Audit & Finance |
Септ. 16, 2024 |
| Financial Analyst - SoD Ops |
Hyderabad (Office) |
India |
Finance |
Corporate |
Audit & Finance |
Септ. 17, 2024 |
| RLT Sasayama_Associate_Finance Business Planning and Analysis |
Sasayama |
Japan |
Finance |
Innovative Medicines |
Audit & Finance |
Септ. 17, 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
Авг. 05, 2024 |
| Treasury & Cash Management Team Lead |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Авг. 12, 2024 |
| R2R Senior Specialist - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 08, 2024 |
| Expert Analyst – Management Reporting |
Prague |
Czech Republic |
Finance |
Corporate |
Audit & Finance |
Окт. 08, 2024 |
| Global Finance Master Data Sr Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
Окт. 08, 2024 |
| Commercial BPA Manager |
Montreal |
Canada |
International |
Innovative Medicines |
Audit & Finance |
Окт. 08, 2024 |